H-Ls(z)-OBut·HCl CAS:5978-22-3
H-Lys(z)-OBut·HCl inobatsira zvikuru mukugadzirwa kwepeptide yakasimba, ichishanda sechivako chikuru chekugadzira mapeptide ane ma sequences chaiwo uye ma structure features. Vaongorori vanoshandisa iyi compound kuti iite kuti amino acids isanganiswe zvakanaka, zvichiita kuti ma complex peptides asanganiswe zvakanaka. Kuenderana kwayo ne coupling reagents dzakasiyana-siyana, resin supports, uye kudzivirira mapoka kunoita kuti ive sarudzo yakasiyana-siyana yekuvaka ma peptide structures akasiyana-siyana akagadzirirwa zvinodiwa zvekutsvagisa. Uyezve, H-Lys(z)-OBut·HCl inowana kushandiswa mukugadzira mishonga mitsva ine peptide, uko kunaka kwayo kwakasimba uye kuvimbika kwakakosha pakuona kuti ma synthetic processes anodzokororwa uye kugadzirwa kwe peptide products yakachena. Mukuwana nekugadzira mishonga, kugadzira kwakarurama ma peptide analogs uye derivatives kwakakosha pakuongorora hukama hwe structure-activity uye kugadzirisa kurapa. Naizvozvo, H-Lys(z)-OBut·HCl inoshanda sechishandiso chakakosha kune masayendisiti ari kuita dhizaini uye kugadzira ma peptide-based compounds ane mukana wekushandiswa mune pharmacological. Muchidimbu, kushanda kwakakura kweH-Lys(z)-OBut·HCl mukugadzirwa kwepeptide, pamwe chete nekuenderana kwayo nemaitiro akajairwa emurabhoritari, kunoita kuti ive chinhu chakakosha muzvishandiso zvevaongorori nevanoongorora mishonga vanoshanda mumakemikari echisikigo, kutsvagisa mishonga, uye kugadzira mishonga.
| Kuumbwa | C18H29ClN2O4 |
| Kuyedza | 99% |
| Chitarisiko | upfu chena |
| Nhamba yeCAS | 5978-22-3 |
| Kurongedza | Diki uye rakakura |
| Hupenyu hweSherufu | makore maviri |
| Kuchengetera | Chengeta munzvimbo inotonhorera uye yakaoma |
| Chitupa | ISO. |








